
    
      OBJECTIVES:

        -  Determine whether there is a relationship between pharmacokinetic measurements of
           paclitaxel and aging.

        -  Determine whether there is a relationship between the toxic effects of paclitaxel and
           aging.

      OUTLINE: Patients are stratified according to age (cohort 1: patients 55 to 64 vs cohort 2:
      patients 65 to 75 vs cohort 3: patients 75 and over).
    
  